Welcome to our dedicated page for Core Scientific SEC filings (Ticker: CORZZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Core Scientific, Inc. Tranche 2 Warrants (CORZZ) provides access to regulatory documents that explain how these warrants relate to Core Scientific’s common stock and broader capital structure. Core Scientific’s filings under the Exchange Act identify CORZZ as a class of warrants listed on the Nasdaq Global Select Market, each whole warrant exercisable for one share of Core Scientific common stock at a specified exercise price.
Through Forms 8-K and other filings, Core Scientific discloses material events affecting CORZZ, such as the satisfaction of trading price conditions that make tranche 2 warrants exercisable for a defined period. These filings describe the warrant terms, including exercise prices and the number of warrants outstanding, and may reference related press releases furnished as exhibits. Investors can review these documents to understand when and how CORZZ can be exercised and how many shares of common stock each warrant represents.
Filings also place CORZZ in the context of Core Scientific’s capital structure and corporate transactions. In connection with the company’s emergence from Chapter 11 reorganization, SEC disclosures outline the issuance of new common stock, tranche 1 warrants, tranche 2 warrants and other securities. Later 8-K filings describe an Agreement and Plan of Merger under which CoreWeave, Inc. is expected to acquire Core Scientific in an all-stock transaction. These documents explain how each share of Core Scientific common stock would convert into CoreWeave Class A common stock and how existing warrants, including tranche 2 warrants, would be adjusted into new warrants exercisable for CoreWeave shares based on an exchange ratio.
On Stock Titan, users can review real-time updates from EDGAR alongside AI-powered summaries that highlight key points from Core Scientific’s 8-Ks and other filings. These summaries help clarify the implications of warrant-related disclosures, merger terms, and other regulatory information without requiring readers to parse every technical detail. The filings page also surfaces information on registered securities, including CORZ, CORZW and CORZZ, so investors can see how the different instruments interact within Core Scientific’s disclosed capital structure.
Vanguard Portfolio Management reported beneficial ownership of 18,843,184 shares of Core Scientific Inc. Common Stock (CUSIP 21874A106), representing 5.97% of the class. The filing shows Vanguard has sole voting power over 228,648 shares and sole dispositive power over 18,843,184 shares. The disclosure notes holdings include securities managed across Vanguard affiliates and funds. The Schedule 13G was signed on 04/29/2026.
Vanguard Portfolio Management reported beneficial ownership of 18,843,184 shares of Core Scientific Inc. Common Stock (CUSIP 21874A106), representing 5.97% of the class. The filing shows Vanguard has sole voting power over 228,648 shares and sole dispositive power over 18,843,184 shares. The disclosure notes holdings include securities managed across Vanguard affiliates and funds. The Schedule 13G was signed on 04/29/2026.
Core Scientific, Inc. is planning a major expansion of its Pecos, Texas campus into a large-scale artificial intelligence data center hub. The company outlines a multi-tiered strategy to grow the site to approximately 1.5 gigawatts of gross power, including about 1.0 gigawatt of leasable power for customers.
Currently, 300 megawatts of gross power at Pecos are used for bitcoin mining, but the site is being transformed into a high-density colocation data center campus for AI infrastructure. The first data hall has reached a key construction milestone with interior foundational footings complete and precast concrete walls arriving as the project moves toward vertical construction.
The campus is already available for lease, with initial capacity still expected in early 2027. Core Scientific has secured an additional 300 megawatts of gross power capacity under contract with its utility provider, developed a scalable behind-the-meter power solution expected to add significant capacity, and obtained more than 200 acres of land to support the planned buildout.
Core Scientific, Inc. is planning a major expansion of its Pecos, Texas campus into a large-scale artificial intelligence data center hub. The company outlines a multi-tiered strategy to grow the site to approximately 1.5 gigawatts of gross power, including about 1.0 gigawatt of leasable power for customers.
Currently, 300 megawatts of gross power at Pecos are used for bitcoin mining, but the site is being transformed into a high-density colocation data center campus for AI infrastructure. The first data hall has reached a key construction milestone with interior foundational footings complete and precast concrete walls arriving as the project moves toward vertical construction.
The campus is already available for lease, with initial capacity still expected in early 2027. Core Scientific has secured an additional 300 megawatts of gross power capacity under contract with its utility provider, developed a scalable behind-the-meter power solution expected to add significant capacity, and obtained more than 200 acres of land to support the planned buildout.
Two Seas Capital and related reporting persons now report beneficial ownership of 13,984,778 Core Scientific (CORZ) common shares, or 4.4% of the class. They state they ceased to be beneficial owners of more than five percent of the stock on April 23, 2026.
The position includes 313,646 shares issuable upon exercise of warrants and options to purchase 3,000,000 shares. These securities are held across affiliated funds and accounts that have delegated sole voting and investment power to Two Seas Capital under investment management agreements.
Two Seas Capital and related reporting persons now report beneficial ownership of 13,984,778 Core Scientific (CORZ) common shares, or 4.4% of the class. They state they ceased to be beneficial owners of more than five percent of the stock on April 23, 2026.
The position includes 313,646 shares issuable upon exercise of warrants and options to purchase 3,000,000 shares. These securities are held across affiliated funds and accounts that have delegated sole voting and investment power to Two Seas Capital under investment management agreements.
Core Scientific officer Todd M. Duchene sold shares in a planned transaction. On April 20, 2026, he completed an open-market sale of 10,000 shares of Core Scientific common stock at a weighted average price of $19.7952 per share under a Rule 10b5-1 trading plan adopted on December 5, 2025.
The shares were sold in multiple trades at prices ranging from $19.53 to $20.08. After this sale, Duchene directly holds 2,000,348 shares of Core Scientific common stock, indicating he retains a substantial equity position in the company.
Core Scientific officer Todd M. Duchene sold shares in a planned transaction. On April 20, 2026, he completed an open-market sale of 10,000 shares of Core Scientific common stock at a weighted average price of $19.7952 per share under a Rule 10b5-1 trading plan adopted on December 5, 2025.
The shares were sold in multiple trades at prices ranging from $19.53 to $20.08. After this sale, Duchene directly holds 2,000,348 shares of Core Scientific common stock, indicating he retains a substantial equity position in the company.
Core Scientific, Inc. plans a private offering of $3.3 billion in senior secured notes due 2031 through subsidiary Core Scientific Finance I LLC. The company expects the issuer to distribute proceeds back to Core Scientific, which plans to repay its delayed draw term loans under a 364‑day bridge credit facility.
Supplemental materials outline six licensed data center projects with CoreWeave, targeting about $7.8 billion in illustrative total revenue and roughly 590 MW of critical IT capacity, backed by long‑term power contracts and a completion guarantee from Core Scientific for project build‑out.
Core Scientific, Inc. plans a private offering of $3.3 billion in senior secured notes due 2031 through subsidiary Core Scientific Finance I LLC. The company expects the issuer to distribute proceeds back to Core Scientific, which plans to repay its delayed draw term loans under a 364‑day bridge credit facility.
Supplemental materials outline six licensed data center projects with CoreWeave, targeting about $7.8 billion in illustrative total revenue and roughly 590 MW of critical IT capacity, backed by long‑term power contracts and a completion guarantee from Core Scientific for project build‑out.
Core Scientific, Inc. executive Todd M. Duchene reported a tax-related share disposition linked to equity compensation. On this Form 4, 16,741 shares of common stock were withheld at $19.08 per share to satisfy withholding tax obligations when restricted stock units vested. After this non-market, tax-withholding disposition, Duchene directly holds 2,010,348 shares of common stock.
Core Scientific, Inc. executive Todd M. Duchene reported a tax-related share disposition linked to equity compensation. On this Form 4, 16,741 shares of common stock were withheld at $19.08 per share to satisfy withholding tax obligations when restricted stock units vested. After this non-market, tax-withholding disposition, Duchene directly holds 2,010,348 shares of common stock.
Core Scientific CEO Adam Taylor reported a routine tax-related share disposition. On the vesting of restricted stock units, 87,355 shares of Common Stock were withheld at $19.08 per share to cover withholding tax obligations.
After this non-market transaction, Taylor directly holds 4,470,033 shares of Core Scientific common stock. Because the shares were withheld for taxes rather than sold on the open market, this filing reflects compensation and tax mechanics more than a change in investment view.
Core Scientific CEO Adam Taylor reported a routine tax-related share disposition. On the vesting of restricted stock units, 87,355 shares of Common Stock were withheld at $19.08 per share to cover withholding tax obligations.
After this non-market transaction, Taylor directly holds 4,470,033 shares of Core Scientific common stock. Because the shares were withheld for taxes rather than sold on the open market, this filing reflects compensation and tax mechanics more than a change in investment view.
Two Seas Capital and affiliates filed an amended Schedule 13D reporting a 5.7% beneficial stake in Core Scientific, Inc. common stock. They collectively report beneficial ownership of 17,918,778 shares, including 313,646 shares issuable upon exercise of warrants and options to purchase 3,534,000 shares.
The position is held across a Strategic Fund, a Global Fund and separate Accounts, with voting and investment power delegated to Two Seas Capital under Investment Management Agreements. The filing also details a range of options positions with exercise prices between $10 and $27 and expirations on various dates in 2026, reflecting both purchased and written options tied to Core Scientific shares.
Two Seas Capital and affiliates filed an amended Schedule 13D reporting a 5.7% beneficial stake in Core Scientific, Inc. common stock. They collectively report beneficial ownership of 17,918,778 shares, including 313,646 shares issuable upon exercise of warrants and options to purchase 3,534,000 shares.
The position is held across a Strategic Fund, a Global Fund and separate Accounts, with voting and investment power delegated to Two Seas Capital under Investment Management Agreements. The filing also details a range of options positions with exercise prices between $10 and $27 and expirations on various dates in 2026, reflecting both purchased and written options tied to Core Scientific shares.
Core Scientific, Inc. officer Todd M. Duchene reported open-market sales of 10,000 shares of Common Stock on April 13, 2026, in two transactions pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2025. The shares were sold at weighted average prices within ranges of $17.94–$18.90 and $18.97–$19.04 per share. Following these sales, Duchene directly holds 2,027,089 shares of Common Stock.
Core Scientific, Inc. officer Todd M. Duchene reported open-market sales of 10,000 shares of Common Stock on April 13, 2026, in two transactions pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2025. The shares were sold at weighted average prices within ranges of $17.94–$18.90 and $18.97–$19.04 per share. Following these sales, Duchene directly holds 2,027,089 shares of Common Stock.
Core Scientific, Inc. officer Todd M. Duchene sold 10,000 shares of Common Stock in an open-market transaction at a weighted average price of $16.4865 per share. After this sale, he directly holds 2,037,089 shares. The trade was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025, and the shares were sold in multiple transactions at prices ranging from $16.285 to $16.78.
Core Scientific, Inc. officer Todd M. Duchene sold 10,000 shares of Common Stock in an open-market transaction at a weighted average price of $16.4865 per share. After this sale, he directly holds 2,037,089 shares. The trade was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025, and the shares were sold in multiple transactions at prices ranging from $16.285 to $16.78.